The OU School of Community Medicine located in Tulsa, OK is a branch of the University of Oklahoma College of Medicine. It is the first medical school of its kind in the nation.

During the past decade, University of Oklahoma-Tulsa conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Oklahoma-Tulsa" #1 sponsor was "University of Oklahoma" with 3 trials, followed by "Yaupon Therapeutics" with 2 trials sponsored, "Abbott Research Group" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Harvest Technologies" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Oklahoma-Tulsa" #1 collaborator was "ALN Implants Chirurgicaux" with 1 trials as a collaborator, "Argon Medical Devices" with 1 trials as a collaborator, "B. Braun Interventional Systems, Inc" with 1 trials as a collaborator, "Bard Peripheral Vascular, Inc." with 1 trials as a collaborator and "Cook Group Incorporated" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "University of Oklahoma-Tulsa" are "AV Fistula" (2 trials), "Mycosis Fungoides" (2 trials), "Alcohol Dependence" (1 trials), "Chronic Renal Failure" (1 trials) and "Contraception" (1 trials). Many other conditions were trialed in "University of Oklahoma-Tulsa" in a lesser frequency.

Most popular intervention types in "University of Oklahoma-Tulsa" are "Drug" (6 trials), "Device" (5 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.04% Mechlorethamine gel" (1 trials), "Acamprosate" (1 trials), "BMAC injection" (1 trials), "Blood Draw" (1 trials) and "Ellipsys Vascular Access System" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Oklahoma-Tulsa" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Oklahoma-Tulsa". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University of Oklahoma-Tulsa, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Oklahoma-Tulsa, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".